Prof. Shusen Wang
Director of Cell Transplant Department
Tianjin First Central Hospital, China
Powerful tools for maximum safety and curative cell for cell therapy and transplant
Thursday, 20th June 2024
13:00 - 14:30 (GMT +8)
View other Time Zones
In recent years, there has been a notable increase in the utilisation and interest surrounding cell therapy and transplant solutions.This is because it encompasses a broad range of medical approaches that utilise cells to treat, repair, or replace damaged tissues, organs, or biological systems within the body. Overall, cell therapy and transplant solutions represent promising avenues for the treatment of various medical conditions, offering the potential to improve patient outcomes, enhance quality of life, and address unmet medical needs. There is also ongoing research and advancements in this field continue to expand the possibilities for regenerative medicine and personalised healthcare.
Let’s take this opportunity to join us for this webinar to see how we can make full use of our current knowledge on cell therapy and transplant solutions.
*This webinar will be delivered in English and simultaneous interpretation is available in Korean and Mandarin.
Who should attend:
- Participants include C-suites, Head of departments, Professors, Clinicians, Laboratory directors, Researchers, Lab managers, Post Doctoral researchers, Lab technicians, Cell therapy and transplant solutions R&D team, Students or any professionals interested in understanding in microbial fermentation.
Key reasons to attend:
- General overview of the emerging technologies transforming the bioindustry.
- Know more about the market trend and development of microbial fermentation.
- Current challenges that microbial fermentation faces and how to navigate around it.
- Success stories for microbial fermentation.
- Understand the market requirements for microbial fermentation
Faculty
Speaker |
|
SpeakerProf. Shusen WangDirector of Cell Transplant Department |
Prof. Wang led his team to complete a series of pioneering pancreatic islet transplantation techniques, including the first case of CiPSC-islet transplantation in the world, the first case of islet after pediatric liver transplantation in the world, and spearheaded finish the "Clinical Technical Operation Standard for Pancreatic Islet Transplantation'' and the " Clinical Technical Operation Standard Islet Preparation in China". Prof. Wang has also directed several national key research and development programs, as well as national natural science foundation projects, and has published over 40 papers as first author or corresponding author in journals such as Nature Medicine, Diabetes, Ebiomedicine, and Transplantation. He has contributed to the compilation of "Chinese Medical Encyclopedia - Organ Transplantation", "Zeng Xianjiu Pancreatic Surgery", and "Experimental Organ Transplantation", and has completed multiple invention patents.
Speaker |
Dr. Gumpei YoshimatsuMD, PhD |
|
SpeakerDr. Gumpei YoshimatsuMD, PhD |
Dr. Gumpei Yoshimatsu is an expert for human islet transplantation and a gastroenterological surgeon. He has many experiences of the clinical human islet isolation for total pancreatectomy with autologous islet transplantation and for allogeneic transplantation into type 1 diabetes patients. He has published 67 papers in the peer-reviewed international journals as original articles, review articles or case reports. He has participated in the international academic meeting such as International Pancreas and Islet Transplant Association, American Transplant congress, American Pancreatic Association and International Hepato-Biliary-Pancreas Surgery, and he has given many presentations there. Moreover, he has worked even on oncological surgery as minimally invasive surgery. He has dedicated the robotic surgery and the laparoscopic surgery. He is a certified skilled surgeon, and he has board certifications as Board Certified Surgeon in Japan Surgical Society, Board Certified Surgeon in Gastroenterology, Board Certified Transplant Surgeon in the Japan Society for Transplantation, and Board Certified Tissue Transplant Medical doctor in Japanese Society of Tissue Transplantation. He is a qualified surgeon in Endoscopic Surgical Skill Qualification System in Japan Society for Endoscopic Surgery and he has a certification of operator for Robotic surgery. He is an International Fellow of American College of Surgeon.
Award:
He won the American Gastroenterological Association Award of young investigator winners in DDW and the President’s Award of Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Speaker |
Prof. Po-Wei LeeDirector |
|
Prof. Po-Wei LeeDirector |
Powei Lee is a medical device engineer from Taiwan. He holds PhD in Chemical Engineering from Taiwan Nation Tsing Hua University. Lee currently works as a director in R&D department at BioGend Therapeutics. For the past decade, Lee had engaged in development of the one-stage cartilage repair technology. He was responsible for scientific research, devices development, clinical trial execution and marketing. He has a wide range of experience and knowledge from design and development of medical device to product registration.
Moderator |
Ms. Guiyang YuPrincipal Product Consultant |
|
ModeratorMs. Guiyang YuPrincipal Product Consultant |
Guiyang Yu, as Principal Product Consultant focused on the biopharma portfolio in Roche CustomBiotech business . She received her Ph.D. degree in Biology from Shanghai Jiao Tong University and joined Roche in 2017.
Live Webinar Date & Time
 |
Date:20th June 2024 at 13:00-14:30 (GMT+8) |
 |
|
Can’t make it?
Don’t worry, register now to view the webinar recording after the event.
The Development of Bioindustry Driven by Advanced Productive Forces
Please view the Korean translation recording here
Thursday, 5th December 2024
13:00 - 14:30 (GMT +8)
View other Time Zones
Join us for an insightful webinar exploring the evolution of the bioindustry as advanced productive forces reshape its landscape. As new technologies and sustainable methods emerge, bioindustries are rapidly evolving to address global challenges in healthcare, food security, and environmental sustainability. This session will provide insights to the latest advancements in biotechnology, synthetic biology, and biomanufacturing, as well as their applications in real-world industries. The webinar will also explore how bioindustry advancements are creating a comprehensive look on how technological developments—ranging from synthetic biology and gene editing to precision fermentation — are revolutionising the bioindustry’s capacity to produce, innovate, and grow.
*This webinar will be delivered in English and simultaneous interpretation is available in Korean and Mandarin.
Who should attend:
- Participants include C-suites, Head of departments, Professors, Clinicians, Laboratory directors, Researchers, Lab managers, Post Doctoral researchers, Lab technicians, Microbial fermentation R&D and manufacturing team, Students or any professionals interested in understanding in microbial fermentation.
Key reasons to attend:
- General overview of the emerging technologies transforming the bioindustry.
- Know more about the market trend and development of microbial fermentation.
- Current challenges that microbial fermentation faces and how to navigate around it.
- Success stories for microbial fermentation.
- Understand the market requirements for microbial fermentation
Faculty
Speaker |
Dr. Min Zhu, PhDSenior VP, CDMO Operations |
|
SpeakerDr. Min Zhu, PhDSenior VP, CDMO Operations |
Dr. Min Zhu is a well-respected professional in the biopharmaceutical industry, with over 17 years of experience in process development, characterization, and validation support. Prior to joining Innoforce, Dr. Zhu served as Director of Protein Science at Boehringer Ingelheim in Fremont. At BI, she was responsible for CMC strategy and cross-functional alignment from process characterization to BLA submission. In addition, she led the technology development and implementation of a next-generation continuous manufacturing platform. Before that, Dr. Zhu led downstream commercial process development, process characterization and validation for several late-stage biologic pipeline products at MedImmune/AstraZeneca. Dr. Zhu has published more than twenty papers in peer-reviewed journals and is a frequent speaker in international biopharmaceutical conferences. In addition to her leadership in the biopharmaceutical community, Dr. Zhu is also passionate about photography and travelling.
Speaker |
Dr. Hyerim Kim, Ph.D
Head of Microbiome Research Center, |
|
SpeakerDr. Hyerim Kim, Ph.DHead of Microbiome Research Center, |
Dr. Hyerim Kim is a basic research pharmacist in South Korea. She earns a PhD in Cancer Biology and Human Genetics from Emory University, USA. Kim currently works as a Head director in Microbiome Research center at Genome and Company. For the five years at Genome and Company, Kim had engaged in more than 5 early-stage microbiome-based drug development and probiotic development projects in cancer, metabolic diseases, neurological disorders, women’s health, and infectious skin disorder.
Speaker |
Dr. Yong Hahk Park, PhDVice President |
|
Dr. Yong Hahk Park, PhDVice President |
Dr. Yong Hahk Park is currently head of Global Business at Sempio Foods Company. Sempio Foods Company produces various consumer goods foods products, ranging from fermented Korean traditional foods such as ganjang(soysauce), gochujang and ssamjang to curries, pasta sauces, canned goods, noodles, teas etc. Sempio is Korea's leading ganjang(soysauce) manufacturer with over 60% market share, and is highly specialized in fermentation research. In addition to traditional food products, Albert is leading the expansion into biotechnology, focusing on the development of bioactive materials based on fermentation technologies. Following family tradition, Albert joined the company in 2017 at the ripe age of 39, where he first started to learn about fermentation technology. In his past life, Albert worked as an engineer developing AI software after receiving his Ph.D. in Artificial Intelligence from the Computer Science Department at UC San Diego. He interned and worked as a software developer at companies such as Google, Samsung, and LG, but now is looking into bio-fermentation technologies at Sempio, which was started by his great-grandfather in 1946.
Speaker |
Dr. Christian WeilkeDirector International Product Management |
|
Dr. Christian WeilkeDirector International Product Management |
Dr. Christian Weilke holds the position of an International Product Manager at Roche CustomBiotech, where he is responsible for the product portfolio for Pharma process control. Christian received a Ph.D. in chemistry, and in 1999 he joined Roche Diagnostics, heading a lab for Research & Development of analytical systems. From 2010 on, he took over responsibilities in the global product management at Roche Custom Biotech, and he is in charge of the Cedex Analyzers for more than 10 years now.
Moderator |
Mr. Tomoyuki FukuiCB Sales Specialist |
|
Mr. Tomoyuki FukuiCB Sales Specialist |
After earning a Ph.D. in molecular biology and conducting research as a postdoctoral fellow, Tomoyuki Fukui joined Roche Diagnostics and currently works in marketing. Leveraging his specialized knowledge and experience, he contributes to creating value in the industry by supporting the sales of raw materials for pharmaceuticals and diagnostics.
Live Webinar Date & Time
|
Date:5th December 2024 at 13:00-14:30 (GMT+8) |
|
|
Can’t make it?
Don’t worry, register now to view the webinar recording after the event.